Johnson & Johnson Talcum Powder Lawsuit Heads to Trial in California, Bernstein Liebhard LLP Reports

NEW YORK, July 10, 2017 /PRNewswire/ -- The first of more than 300 ovarian cancer lawsuits involving Johnson & Johnson's talcum powder products will head to trial today in Los Angeles Superior Court. The case tapped to go before a jury was filed on behalf of a 63-year-old woman who allegedly made the company's talc-based powders a regular part of her daily feminine hygiene routine for decades prior to her diagnosis. (Johnson & Johnson Talcum Powder Cases, number JCCP4872)

"This trial is vitally important, as it is considered a bellwether case. The verdict in this lawsuit could provide insight into how juries might decide similar claims pending in California's talcum powder litigation," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices, drugs and consumer products. The Firm is offering free legal reviews to women who were diagnosed with ovarian cancer that may be associated with Johnson & Johnson's talc-based powders.

Nationwide Talcum Powder Litigation

Johnson & Johnson has been named a defendant in more than 3,000 talcum powder lawsuits currently pending in courts around the country, all of which were filed on behalf of women who allegedly developed ovarian cancer following the regular and repeated use of the company's talc-based powders for feminine hygiene purposes. Plaintiffs claim that Johnson & Johnson officials were aware of research published as early the 1970s that suggested such a link, yet failed to warn the public in order to protect profits derived from its Baby Powder and Shower-to-Shower product lines.

The California trial will be the first convened outside of Missouri's 22nd Circuit Court in St. Louis, where one of the nation's largest talcum powder litigations is currently underway. So far, only one Missouri jury has rendered a verdict in favor of Johnson & Johnson. Plaintiffs in four cases have been awarded compensatory and punitive damages amounting to $110 million, $70 million, $72 million and $55 million. A mistrial was declared in the state's sixth trial just last month. (Case No. 1422-CC09326-01)

Women who were diagnosed with ovarian cancer following the long-term use of talc-based powder for feminine hygiene purposes may be eligible to file their own talcum powder lawsuit. To learn more, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.

About Bernstein Liebhard LLP 
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.

Bernstein Liebhard LLP 
10 East 40th Street 
New York, New York 10016 
800-511-5092

ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information: 
Sandy A. Liebhard, Esq. 
Bernstein Liebhard LLP 
info (at)consumerinjurylawyers(dot)com
http://www.rxinjuryhelp.com/  
https://plus.google.com/115936073311125306742?rel=author

SOURCE Bernstein Liebhard LLP

Related Links

http://www.bernlieb.com